月度归档： 2025 年 5 月

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - May 27, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce the following internal GMG run engine test results when G® Lubricant was added to a Caterpillar 22 kVA diesel engine run at an 80% Load. Test results show a 10% increase in energy efficiency (kwh/litres), and also a 33% reduction in harmful diesel engine exhaust particulate matter emissions, when three doses of G® Lubricant, with a maximum graphene dosage of 0.03%, was added to the standard diesel engine oil.It is noted that the test engine was not operating optimally before G® Lubricant was added - the engine was overheating at long runs of sustained high loads. As a result, after the initial dose of G® Lubricant was added, an additional two dosages of G® Lubricant were used to hopefully bring the engine into a more stable operating regime, an outcome that was generally achieved.Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_gmg_image.jpgBuy Now at: www.G-Lubricant.com Figure 2 and 3 show the table and graph distribution of engine efficiency of the various dosages of G® Lubricant versus the baseline.Baseline Diesel Engine OilEngine Efficiency (kwh/litres)G® Lubricant (0.01%)Engine Efficiency (kwh/litres)G® Lubricant (0.02%)Engine Efficiency (kwh/litres)G® Lubricant (0.03%)Engine Efficiency (kwh/litres)3.043.36 (10% increase)3.35 (10% increase)3.36 (10% increase)Figure 2: Engine Efficiency Performance Increase from G® LubricantFigure 3: % Distribution of Fuel Efficiency Relative to BaselineTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_d626526a342c2ac9_005full.jpgFigures 4 and 5 show the table and graph distribution of diesel engine particulate matter emissions of the various dosages of G® Lubricant versus the baseline.Baseline Diesel Engine OilParticulate Matter (ppm)G® Lubricant (0.01%)Particulate Matter(ppm)G® Lubricant (0.02%)Particulate Matter (ppm)G® Lubricant (0.03%)Particulate Matter (ppm)20.9715.56 (26% reduction)14.55 (31% reduction)13.97 (33% reduction)Figure 4: Engine Emission Particulate Matter Reduction from G® LubricantFigure 5: % Distribution of Particulate Matter in Emissions Relative to BaselineTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_d626526a342c2ac9_006full.jpgFigure 6 shows the exhaust emissions of the diesel engine at various dosages of G® Lubricant, versus the baseline which shows similar levels as the baseline test runs. More testing is being done to get more detail on the impact of G® Lubricant across engine emissions. % O2ppm COppm NO% CO2°C FTppm NOxppm NO2Baseline (DEO)7.8151.5359.69.830.0362.22.7DEO + 1% G® Lubricant7.5161.3383.510.028.1386.73.3DEO + 2% G® Lubricant7.5170.6377.010.027.6379.82.8DEO + 3% G® Lubricant7.4184.8388.710.128.4391.42.7Figure 6: Emissions Data for G® Lubricant Relative to BaselineDetailed Equipment and Process for Testing G® LubricantThe following describes the equipment used and the process followed by the Company in demonstrating the fuel saving demonstration of the G® Lubricant in the diesel engine generator:The same testing equipment, data systems and processes were used which was verified by the University of Queensland and detailed in GMG's previous press release on the 25th February, https://graphenemg.com/gmg-unveils-g-lubricant-engine-performance-testing-results-a-transformative-graphene-energy-saving-solution-for-the-multi-trillion-dollar-global-liquid-fuel-industry/GMG also added the following testing equipment to the testing program:Testo 340 Diesel Kit 2 engine emissions test kit which was newly calibrated by the third-party supplier.PDSA DPM-RT-2 particulate matter test unit which was newly calibrated by the third-party supplier.A 22kVA Caterpillar diesel engine generator (with 1,959 hours of run time) was setup in the GMG Richlands warehouse.The generator was connected to a 40-kW power load bank which consumed the energy produced by the generator and created the load and a 500-litre self-contained fuel tank.Two calibrated flow sensors were connected (inflow and return/outflow) to the fuel lines and to a data logger which recorded the fuel consumption.An Energy Analyzer was used to log and track energy produced by the generator.Tests were conducted on 80% loads of the engine from the 40-kW power load bank - 22 kW.A baseline to record diesel fuel consumption under normal engine oil and operating conditions was completed with newly changed recommended premium diesel engine oil and a new oil filter. This oil change was carried out by a professional engine maintenance service company.The engine was run at 80% load and the baseline and G® Lubricant data set used for the analytics is when the maximum ambient temperature for the day was less than 33 degrees Celsius and relative humidity was between 50% and 80% with no rain. Fuel consumption for diesel engines changes when operating in rain or very high humidity or temperatures, so the fuel consumption data baseline and G® Lubricant engine oil additive performance testing were excluded for these times.Only steady state data was used and so any variance or anomalous data seen in either baseline or G® Lubricant datasets were removed from the analytics. Data sets were grouped into minute blocks.Once the baseline fuel tests were completed, G® Lubricant with approximately 1:100 concentration was mixed at approximately 1% ratio by weight into the existing engine oil. This was done another 2 times. The end ratio of GMG's Graphene to the diesel engine oil was approximately 3:10,000 by weight.GMG's Managing Director and CEO, Craig Nicol, commented: "G® Lubricant is not only increasing fuel efficiency it is also reducing particulate matter - which is amazing to see - we will need to do more tests to see what the long-term performance is for this."GMG is continuing to conduct more tests to determine the total performance regime of the G® Lubricant. These performance tests will be announced as the information becomes available.GMG's Chairman and Director, Jack Perkowski, commented: "Fantastic news - G® Lubricant testing data are exciting - well done to the team - showing great promise as a way to reduce fuel costs and emissions across the multi-trillion dollar liquid fuels industry."About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the potential of G® Lubricant to optimize efficiency and power for stationary or mobile engines, the potential of G® Lubricant to reshape the future of the global liquid fuels industry, GMG's intention to commercialise and market G® Lubricant, the progress of the Company's patent applications, the potential market for G® Lubricant and the potential revenue available for G® Lubricant.Such forward-looking statements are based on a number of assumptions of management, including, without limitation that G® Lubricant has the potential to optimize efficiency and power for stationary or mobile engines, that G® Lubricant has the potential to reshape the future of the global liquid fuels industry, that GMG will commercialize and market G® Lubricant, that the Company's patent applications will progress as anticipated, and that the potential market and revenue available for G® Lubricant will be as currently forecasted. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that G® Lubricant will not offer an innovative solution that optimizes efficiency and power for stationary or mobile engines, that G® Lubricant will not reshape the future of the global liquid fuels industry, that GMG will commercialize and market G® Lubricant as anticipated, that the Company's patent applications will not progress as currently anticipated, that the potential market and revenue available for the G® Lubricant product is not as currently calculated, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/253490 Copyright 2025 ACN Newswire via SeaPRwire.com.

- 论坛匯聚超过80位全球医疗衞生领域的政府官员及组织、科研先驱、投资者及企业领袖，共同探讨医疗科技、银髮健康、医健体系等方面的国际合作前景；首设「银髮健康专章」，聚焦应对人口老化- 阿兹海默基因研究之父John Hardy教授、2024-2025年亚太经合组织健康工作组主席Victor Yosef Melt Campos医生及世界衞生组织驻华代表Martin Taylor等星级嘉宾亲临论坛，分享最新医疗创新发展- 香港国际医疗及保健展聚焦领先医疗技术、乐龄科技及绿色方案三大范畴，网罗世界最新医疗健康器械、产品和应用方案，包括不少应用了AI人工智能的方案- 医疗展吸引13个国家及地区、约300家展商齐聚一堂，来自英国、泰国及以色列的展团，以及新加坡、德国、意大利和卢森堡的展商首度参展香港，2025年5月27日 - (亚太商讯 via SeaPRwire.com) - 由香港贸易发展局（香港贸发局）策动的「国际医疗健康周」今日隆重开幕，重点旗舰活动之一第五届「亚洲医疗健康高峰论坛」（ASGH）在今明两日（5月26至27日）假湾仔香港会议展览中心盛大举行，以「全球协作 共创未来」（Fostering Global Collaboration for a Shared Future）为主题，匯聚超过80位来自世界各地的医疗领袖与专家，共同探讨行业未来发展方向与合作机遇。另一旗舰活动第16届「香港国际医疗及保健展」（医疗展）亦于同日展开（5月26至28日），匯聚约300家来自13个国家及地区的参展商，聚焦领先医疗技术、乐龄科技及绿色方案，包括不少应用了AI人工智能的方案，促进环球业界合作。论坛开幕环节由香港贸发局主席林建岳博士致欢迎辞，他表示：「当前全球医疗健康领域正面对多项挑战，涵盖下一波传染病大流行、人口老化带来的医疗需求以及健康公平等议题。这些问题极需全球社会共同关注与协作，以保障世界各地社群的健康福祉。踏入第五届，『亚洲医疗健康高峰论坛』已成为全球医疗业界的瞩目盛事，成功促成多个医疗创新的投资与合作项目，令我们引以为傲。同期举办的『香港国际医疗及保健展』，云集全球最新医疗科技方案，包括医院仪器、復康及长者护理用品和生物科技等。作为『国际医疗健康周』的旗舰活动，论坛与医疗展将进一步彰显香港致力与各界携手，推动创新医疗健康产业发展。」香港特别行政区行政长官李家超致开幕辞时表示：「本届论坛以『全球协作 共创未来』为主题，再次肯定香港作为区域医疗创新枢纽的关键角色。『一国两制』下，香港与中国内地及全球保持独特联繫。作为全球最自由经济体及三大国际金融中心之一，我们提供高效、开放与公平的营商环境，并拥有健全的知识产权保护制度。我们维持资讯、资金、货物与人才自由流动。香港亦正积极发展为科学创新、技术发展与国际教育枢纽。」国家衞生健康委员会副主任曹雪涛院士发表特别致辞时指出：「中国推动医疗领域有序、扩大开放、以及稳步推进外商独资医院试点，引进中外合适、合资、合作的高水平医院资源。希望外资企业加快本土化进程，推进中高端产品本土化升级，实现合作共赢 。」此外，大会亦邀得世界衞生组织总干事谭德塞博士在论坛开幕环节发表视像致辞，他表示：「今年论坛的主题贴合全球公共衞生正面临的挑战。世衞近日通过谈判歷时三年半的《大流行协定》，体现全球衞生领域真正的国际合作精神。共同威胁需要共同责任，透过共同努力，我们可以为所有人建立一个更健康、更安全、更公平的世界。」匯聚各国星级行业领袖 共商全球协作机遇今日的「主题环节I - 塑造更公平及可持续的医疗体系」，由香港特别行政区政府医务衞生局局长卢宠茂教授及中华人民共和国工业和信息化部消费品工业司一级巡视员冯海沧发表特别致辞，卢宠茂教授表示：「构建可持续医疗体系需要人才和充足的医疗人力。政府已通过多管齐下的策略应对人力短缺问题，包括增加本地大学的招生名额、吸纳合资格的非本地培训医护人员。此外，2024年施政报告宣佈，政府支持设立第三间医学院的计划。事实上，香港已拥有两间跻身全球前30的顶尖医学院，但我们既有能力，亦有需要发展第三间医学院。该医学院将採取创新的战略定位，与现有两间医学院实现优势互补，共同推动医疗教育与产业发展。」及后的讨论环节由香港大学教研发展基金主席徐立之教授主持，聚焦医疗体系在应对全球挑战所面对的关键问题，由世界衞生组织驻华代表Martin Taylor及香港科技大学校长叶玉如教授等嘉宾，分享宝贵经验与前瞻见解，为全球医疗领域提供启发。叶玉如教授指出：「大学不仅是学术机构，更是连结全球的中立平台及创新的引擎，其独特地位能跨越学科、产业与国家之间的鸿沟。」「主题环节II - 全球协作 共创未来」获多位国际重量级嘉宾出席，包括曾担任日本首相官邸内阁府特别顾问的DEFTA Partners集团主席兼行政总裁原丈人等，共同探讨全球医疗健康合作趋势，为建构更具协同效应的全球医疗格局注入新思维。在「与环球医疗衞生专家对谈」，大会邀得英国伦敦大学学院（UCL）皇后广场神经学研究院神经疾病分子生物学讲座教授，并享有「阿兹海默基因研究之父」美誉的国际知名神经遗传学家John Hardy教授，分享对阿兹海默症等神经退行性疾病未来研究和治疗的展望，他表示：「关于阿兹海默症治疗，我认为有两大进展可能很快便实现：一是提升早期诊断准确度，二是开发能绕过血管类淀粉蛋白的新药。在药物研发方面，我们致力延缓病情恶化。若能釐清导致恶化的根本机制，就能找到治疗的方法，目前已有令人振奋的新发现。」「健康中国2030」是中国国民健康相关政策的规划蓝图，在「实现『健康中国2030』与医健产业高质量发展」中，江苏恒瑞医药股份有限公司执行副总裁张连山博士及默克集团全球执行副总裁兼默克中国总裁何慕麒等嘉宾，一同探讨内地医疗市场发展机遇，剖析国内医疗创新生态系统的发展趋势，为国际合作开闢新途径。多元议题匯聚前瞻洞见 银髮健康专章探索新商机大会首次与香港科技大学合办以「创造医疗新未来」为题的两场专题环节，伦敦帝国学院医学院副院长（研究）Graham Cooke教授等嘉宾，聚焦人工智能在医疗领域的潜能，向与会者分享创新科技如何推动医疗新突破。此外，同日的「展望基因及细胞疗法的前景」、「女性健康新焦点」等环节亦紧扣全球医疗发展脉搏。延续今日的深度对话，明日将呈上更精彩的讨论环节。大会今年首设「银髮健康专章」，聚焦应对人口老化。Cedars-Sinai先进老年治疗学中心主任James L. Kirkland教授等嘉宾将聚首明天上午的「迎接银髮海啸：老年医学与长寿科技的发展」，深入探讨如何应对人口老化所带来的挑战，剖析银髮市场的未来发展趋势与潜在投资机遇。此外，全球知名的嘉宾明日将亲临现场，分享宝贵经验及真知灼见。养和医疗集团营运总监李维文及法国国家公立医院研究委员会(CNCR)总裁Karim Asehnoune教授等嘉宾将在「医健产业未来协作新模式」剖析如何透过多方持份者的协作，推动医健产业的可持续发展。而上海中医药大学首席教授兼中药学院名誉院长徐宏喜教授等嘉宾，亦将于「中西医药结合促进全球健康」讨论中西医药结合的最新发展与商业潜力。同时，「下一波神经科学创新趋势」、「如何利用数据化医疗重塑病人旅程」、「癌症治疗新方向」等多个环节亦将陆续登场。全球医健资源对接平台 创新合作新机遇除专题讨论，论坛亦致力促进与会者洽谈合作，例如环球投资项目对接环节，透过线上或线下一对一会议，为全球各地医健领域的投资者及项目拥有人搭建国际合作与投资桥樑。ASGH亦设立ASGH Business Hub展览专区，云集超过170个来自澳洲、泰国、上海及厦门等13个国家及地区的创新科技企业和获奖项目。其中InnoHealth Showcase展区作为探索商机和创新方案的平台，集合逾70家由创新科技署连同数码港及六家本地大学牵头组织的企业和项目，围绕医药与治疗、智能医疗、医疗器械与诊断，以及社区健康与保健四大重点类别。展区中不少项目聚焦应对人口老化问题，以作「银髮健康专章」的展览环节，如阿兹海默症的早期血液检测技术等，展现出长者医疗方面的前沿实力与潜在机遇。融匯全球顶尖科技成果 全面展示医健产业未来由香港贸发局主办、香港医疗及保健器材行业协会协办的第16届香港国际医疗及保健展同步于今日揭幕，以「智慧医健 创新体验」为主题，聚焦领先医疗技术、乐龄科技及绿色方案三大范畴，网罗世界最新医疗健康器械、产品和应用方案。在领先医疗技术方面，英国展团的London Medical Exchange（展位号码: 3F-H15 ）带来全自动人工智能患者监测系统，藉以改善患者护理，将医疗从被动应对转变为主动预防。而香港大学公共衞生学院研究团队成立的卓匯生物科技（展位号码: 3F-G04），带来了「唿吸类器官平台」，可以透过採集个别人士鼻咽或咽喉唾液样本，预测一旦感染唿吸道病毒后，身体将作出甚么反应，让医护更精准用药。乐龄科技方面，香港科技园展团的医念科技（展位号码: 3F-G04），展出认知障碍评估应用程式，透过让中老年人使用电子仪器打麻雀等，以人工智能进行评估及提供个人化脑部训练，帮助他们预防和及早发现患上认知障碍，系统亦可以为患者监测病情。首次参展的香港社会服务联会亦将带来乐龄科技和产品，涵盖的范畴包括復康及行动辅助、支援认知障碍患者和照顾者，及智能家居。社联还会在展会介绍其乐龄科技教育及租赁服务，以及供大众认识和租用乐龄科技的网上平台，让长者、復康人士、照顾者等人士体验使用乐龄科技产品，及按需要租用或购买，过程中跨专业团队会提供支援。社联希望藉展会吸引其他商家协作，扩展服务，令更多市民受惠。绿色方案方面，同属香港科技园展团的MassPhoton（展位号码: 3F-H18）展示结合半导体技术和智能控制技术的紫外光消毒系统，可以更有效、更节能地为空气、水和物件表面消毒。今年医疗展吸引来自13个国家及地区、约300家展商齐聚一堂，当中英国、泰国及以色列的展团，以及新加坡、德国、意大利和卢森堡的展商首度参与，亦有七家香港本地大学、香港科技园展团率领的逾30家创科企业，及香港医疗及保健器材行业协会带来的逾20家医疗企业参展，展示本地创新实力。展览设有多个专题展区，包括：生物科技、医院仪器、復康及长者护理用品、初创专区，和香港医疗及保健器材行业协会专属展区等，焦点展品包括人工智能康復系统、便携式超声诊断系统及智慧医院机器人等多项前沿科技成果。医疗展期间亦设有多元化活动，包括论坛、研讨会及交流酒会等。明天会有两场以大湾区医疗为主题的论坛，上午由香港医疗及保健器材行业协会协办的论坛「大湾区的医疗科技枢纽」邀请多位业界专家，分享生物医药创新的知识产权策略、如何整合资源以开发大湾区医疗科技市场，及在大湾区推广医疗科技的成功经验等。下午的「粤港澳大湾区医疗器械监管与协作发展」论坛，将由国家药品监督管理局医疗器械技术审评检查大湾区分中心、衞生署疗器械科及通标标准技术服务的专家，共同探讨相关领域的最新发展、管理制度和法规，促进区域间的监管协作与创新交流。今届展览将继续沿用「EXHIBITION+」（展览+）模式举行，除了实体展览，环球展商、业界人士和买家亦可透过「商对易」（Click2Match）智能商贸配对平台进行洽商，直至 6月 4日，以促成更多合作。除了亚洲医疗健康高峰论坛和香港国际医疗及保健展，「国际医疗健康周」亦包含2025年医院管理局研讨大会等其他精彩活动。图片下载：https://bit.ly/43xCK2b香港特别行政区政府及香港贸易发展局主办的第五届「亚洲医疗健康高峰论坛」于5月26至27日假香港会议展览中心举行，并以「全球协作 共创未来」作为主题。香港贸发局主席林建岳博士致欢迎辞。香港特别行政区行政长官李家超致开幕辞。国家衞生健康委员会副主任曹雪涛院士发表特别致辞。世界衞生组织总干事谭德塞博士在开幕环节发表视像讲话。论坛邀请到英国伦敦大学学院（UCL）皇后广场神经学研究院神经疾病分子生物学讲座教授，曾获颁生命科学突破奖以及大脑研究奖并享有「阿兹海默基因研究之父」美誉的国际知名神经遗传学家John Hardy教授作为专题演讲嘉宾。环球投资项目对接环节透过线上或线下一对一会议，为全球各地医疗保健领域搭建国际合作与投资桥樑。论坛促成多项合作协订，开展更多医健产业内不同领域的具体合作。第16届香港国际医疗及保健展（医疗展）以「智慧医健 创新体验」为主题，聚焦领先医疗技术、乐龄科技及绿色方案三大范畴，网罗世界最新医疗健康器械、产品和应用方案。香港科技园展团的医念科技，展出认知障碍评估应用程式，透过让中老年人使用电子仪器打麻雀等，以人工智能进行评估及提供个人化脑部训练，帮助他们预防和及早发现患上认知障碍。首次参展的香港社会服务联会带来乐龄科技和产品，涵盖的范畴包括復康及行动辅助、支援认知障碍患者和照顾者，及智能家居。匈牙利展团再度参展，带来评估健康状况的仪器及医疗相关的课程等。相关网页国际医疗健康周：https://internationalhealthcareweek.hktdc.com/sc亚洲医疗健康高峰论坛︰https://www.asiasummitglobalhealth.com/conference/asgh/sc论坛议程︰https://www.asiasummitglobalhealth.com/conference/asgh/sc/programme论坛讲者名单︰https://www.asiasummitglobalhealth.com/conference/asgh/sc/speaker香港国际医疗及保健展：https://www.hktdc.com/event/hkmedicalfair/sc精选产品及详情：https://www.hktdc.com/event/hkmedicalfair/sc/product活动及研讨会议程：https://www.hktdc.com/event/hkmedicalfair/sc/intelligence-hub传媒查询新闻界如有查询，请联络圆通财经公关有限公司：宋柳逸电话：(852) 3428 5691电邮：lsong@yuantung.com.hk梁婉彤电话：(852) 3428 2361电邮：tleung@yuantung.com.hk香港贸易发展局传讯及公共事务部：亚洲医疗健康高峰论坛夏妙婷电话：(852) 2584 4575电邮：sharon.mt.ha@hktdc.org黄家欣电话：(852) 2584 4524电邮：katy.ky.wong@hktdc.org张敏萱电话：(852) 2584 4137电邮：jane.mh.cheung@hktdc.org香港国际医疗及保健展石婉婷电话：(852) 2584 4537电邮：kelly.yt.shek@hktdc.org刘茸电话：(852) 2584 4472电邮：clayton.y.lauw@hktdc.org香港贸发局新闻中心︰http://mediaroom.hktdc.com/tc香港贸易发展局简介香港贸易发展局(香港贸发局)是于1966年成立的法定机构，负责促进、协助和发展香港贸易。香港贸发局在世界各地设有超过50个办事处，其中13个设于中国内地，致力推广本港作为双向环球投资及商业枢纽。 香港贸发局通过举办国际展览会、会议及商贸考察团，为企业(尤其是中小企)开拓内地和环球市场的机遇。香港贸发局亦通过研究报告和数码资讯平台，提供最新的市场分析和产品资讯。有关香港贸发局的其他资讯，请浏览www.hktdc.com/aboutus/tc。 Copyright 2025 亚太商讯 via SeaPRwire.com.

- The Asia Summit on Global Health (ASGH) gathers over 80 government officials and organisations, research pioneers, investors, and business leaders to explore international collaboration on medical technology, silver health, and healthcare systems. A dedicated “Silver Health Chapter” debuts this year to spotlight the ageing population.- Renowned speakers include Prof John Hardy, the “father of Alzheimer’s disease genetic studies”; Dr Victor Yosef Melt Campos, Chair (2024-2025) of APEC Health Working Group and General Director of International Cooperation at the Ministry of Health of Peru; and Martin Taylor, Representative to China of the World Health Organization. They will share insights on the latest developments in medical innovation.- The Hong Kong International Medical and Healthcare Fair (Medical Fair) focuses on MedTech, GeronTech, and green solutions, featuring the latest medical health devices, products, and solutions including many AI-powered innovations.- The Medical Fair has attracted some 300 exhibitors from 13 countries and regions. Participating with pavilions for the first time are Israel, Thailand, and the UK, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg.HONG KONG, May 26, 2025 - (ACN Newswire via SeaPRwire.com) – International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), officially opened today. One of its flagship events, the fifth Asia Summit on Global Health (ASGH), takes place today and tomorrow (26 and 27 May) at the Hong Kong Convention and Exhibition Centre (HKCEC). Under the theme Fostering Global Collaboration for a Shared Future, the summit brings together more than 80 healthcare leaders and experts from around the world to explore the future direction of the industry and collaboration opportunities. Another flagship event, the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), also kicks off today (26 to 28 May), and features some 300 exhibitors from 13 countries and regions, showcasing cutting-edge MedTech, GeronTech, and green solutions, including many AI-powered innovations, to foster global industry collaboration.The ASGH opened with welcome remarks delivered by HKTDC Chairman Dr Peter K N Lam.  “The global health sector is currently facing challenges, including a resurgence in infectious diseases, coupled with the growing needs of an ageing population and ongoing health equity concerns. These issues demand urgent attention and collective action to protect communities worldwide. Now in its fifth edition, ASGH is a key event for the global healthcare industry, and we are proud that connections made through ASGH have enabled many new investments and collaborations in healthcare innovation. Alongside ASGH, the Hong Kong International Medical and Healthcare Fair is taking place. There, you will find the latest HealthTech solutions from around the globe, with a particular focus on hospital equipment, rehabilitation, elderly care and biotech. As anchor events of the International Healthcare Week, ASGH and Medical Fair highlights Hong Kong’s commitment to working with partners to nurture an innovative health and medical sector,” Dr Lam said.In his opening speech, Hong Kong SAR Chief Executive John Lee said: "Under the theme of "Fostering Global Collaboration for a Shared Future", this summit reaffirms Hong Kong's pivotal role as a leading health innovation hub in the region. Under the "one country, two systems" principle, Hong Kong enjoys unique connectivity with both Mainland China and the world. As the world's freest economy and one of the top three international financial centres, we offer an efficient, open and fair business environment with robust intellectual property protection. We maintain free flows of information, capital, goods and talent. We are also emerging as a leading hub for scientific innovation, technological advancement and world-class education.”Prof Cao Xuetao, Vice-Minister of the National Health Commission of the People’s Republic of China, gave special remarks, noting: "China continues to open up and welcomes leading foreign-owned hospitals into the market through investment or joint ventures. We hope that our global partners can further localise and upgrade their mid-to-high-end products, resulting in win-win outcomes for all.”Additionally, Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), delivered remarks at the opening session via video link and stated, “The theme of ASGH could not be more appropriate given the challenges facing global health at the moment. The WHO Pandemic Agreement has been adopted recently. It was negotiated over the past three and a half years and shows a true spirit of international collaboration for global health. By working together, we can build a healthier, safer, and fairer world for all.”Global industry leaders gather to explore opportunities for international collaborationToday's Plenary Session I: Shaping a More Equitable and Sustainable Health System, featured keynote remarks by Prof Lo Chung-mau, Secretary for Health of the HKSAR Government, and Feng Haicang, Level I Bureau Rank Official of Department of Consumer Goods Industry, Ministry of Industry and Information Technology of the People's Republic of China.  Prof Lo Chung-mau, stated: “A sustainable health system requires talents and enough healthcare manpower. While the Government has been addressing the issue of manpower shortage through a multipronged strategy, by increasing the number of intakes for local universities and admitting qualified non-locally trained healthcare workers, the 2024 Policy Address announced that the Government supports the plan to establish a third medical school. Indeed, Hong Kong has already hosted two top 30 world class medical schools but we have the ability and the need to develop the third one which shall adopt an innovative strategic positioning in pursuit of complementary development with the two existing ones.” The session was moderated by Prof Tsui Lap-chee, Chairman of the University of Hong Kong Foundation for Educational Development and Research, focused on key issues faced by healthcare systems in addressing global challenges. Distinguished speakers included Martin Taylor, Representative to China of the WHO; and Prof Nancy Ip, President of the Hong Kong University of Science and Technology. They shared valuable experiences and forward-looking insights to inspire the global healthcare field.Prof Nancy Ip noted: “Universities are more than academic institutions. They are global connectors, neutral platforms, and also engines of innovation, uniquely positioned to bridge divides between disciplines, industries, and also nations.”Distinguished international speakers of Plenary Session II: Fostering Global Collaboration for a Shared Future included Ambassador George Hara, Group Chairman and CEO of DEFTA Partners and former Special Advisor to the Cabinet Office of the Prime Minister of Japan. They jointly explored trends in global healthcare collaboration, injecting new ideas into constructing a more synergistic global healthcare landscape.The summit invited Prof John Hardy, known as the “father of Alzheimer’s disease genetic studies”, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, to share his outlook on future research and treatment of neurodegenerative diseases such as Alzheimer's in the Dialogue with Global Pioneer in Health session.Prof John Hardy remarked: “For Alzheimer's treatment, I think that two changes can happen quite quickly: improvements in earlier diagnosis, and development of drugs that bypass the blood vessel-based amyloid. What we want to do with drugs is slow decline. If we understand what underpins that decline, it gives us targets, and we’re very excited by some of the findings in that area now.”“Healthy China 2030” serves as the national blueprint for healthcare policy development in Mainland China. In the session Beyond “Healthy China 2030”: Driving Health Innovation, Dr Zhang Lianshan, Executive Vice President, Jiangsu Hengrui Pharmaceuticals Co., Ltd.; and Marc Horn, Executive Vice President of Merck and President of Merck China, explored opportunities in the mainland healthcare market, analysing emerging trends in China's healthcare innovation ecosystem to open new pathways for international collaboration with other speakers.Diverse topics converge with forward-looking insights and the Silver Health Chapter explores new business opportunitiesFor the first time, the summit co-organised two thematic sessions with the Hong Kong University of Science and Technology under the overarching theme Shaping the Future of Healthcare. Speakers included Prof Graham Cooke, Vice-Dean (Research) of Faculty of Medicine at Imperial College London. They focused on the potential of AI in the medical field, sharing with participants how innovative technologies are driving new breakthroughs in healthcare. Additionally, sessions on Peeking into the Future of Gene and Cell Therapies and Women’s Health in Focus were also closely aligned with global medical development trends.Continuing today's in-depth dialogues, more exciting sessions will be presented tomorrow. For the first time, the summit will feature a Silver Health Chapter focusing on addressing the challenging ageing societies. Speakers including Prof James L. Kirkland, Director of Cedars-Sinai’s Centre for Advanced Gerotherapeutics, will gather at tomorrow morning's session Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology to delve into how to address the challenges brought by an ageing population, analysing future development trends and potential investment opportunities in the silver economy market.Furthermore, globally renowned speakers will be present tomorrow to share their valuable experiences and insights. Wyman Li, Chief Operating Officer of HKSH Medical Group; Prof Karim Asehnoune, President of National Committee for Public Hospital Research (CNCR), and other speakers will analyse how to promote the sustainable development of the healthcare industry through collaboration among different stakeholders in the session, Reinventing the Business of Healthcare through Partnerships. Prof Xu Hongxi, Distinguished Professor and Honorary Dean of Shanghai University of Traditional Chinese Medicine and other guests will discuss the latest developments and commercial potential of integrating Chinese and Western medicine in the session The Convergence of Chinese and Western Medicine in Global Health. Sessions on The Next Wave of Innovations in Neuroscience, Data-driven Healthcare Transforming Patient Journey and The Changing Face of Cancer will also be held tomorrow.A global platform for healthcare resource matchmaking to foster opportunities for innovative collaborationIn addition to thematic discussions, the summit also aims to bridge global collaboration among participants. For example, the ASGH Deal-making facilitates one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations.The summit has established the ASGH Business Hub, which brings together more than 170 innovative technology companies and award-winning projects from 13 countries and regions, including the mainland (Shanghai and Xiamen), Australia, and Thailand. The InnoHealth Showcase serves as a platform to explore business opportunities and innovative solutions and highlights more than 70 healthcare start-ups and projects led by the Innovation and Technology Commission, Cyberport, and six local universities. The showcase is structured around four key categories: pharmaceuticals and therapeutics, AI and Digital Health, medical devices and diagnostics, and community health and wellness. As part of the “Silver Health Chapter”, some of the showcased projects address the challenges of an ageing population, including early blood tests for Alzheimer’s disease, demonstrating cutting-edge capabilities and market potential in elderly healthcare.Integrating global innovations to showcase the future of healthcareThe Hong Kong International Medical and Healthcare Fair also opened today, organised by the HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA). Under the theme Innovations Boosting Smart Health Experience, this year’s Fair focuses on three key areas: MedTech, GeronTech and green solutions, featuring the latest medical health devices, products, and solutions.In the field of MedTech, UK exhibitor London Medical Exchange (Booth No: 3F-H15) presents a fully automated AI-powered patient monitoring system designed to improve patient care, transforming healthcare from reactive to proactive. Meanwhile, C2iTech (Booth No: 3F-G04), established by a research team from the School of Public Health at The University of Hong Kong, showcases a Respiratory Organoid Platform (ROP). By analysing nasopharyngeal or throat saliva samples from individuals, the platform predicts their likely response to respiratory virus infections, enabling more precise and personalised treatment by healthcare professionals.In the GeronTech segment, Medmind Technology (Booth No: 3F-G04), from the Hong Kong Science and Technology Parks Corporation (HKSTP) Pavilion, introduces an app for cognitive impairment assessment. The tool allows middle-aged and elderly users to play digital mahjong and other games, with AI used to assess their cognitive status and offer personalised brain training, helping prevent and detect early signs of cognitive decline. The system can also monitor patient conditions over time.The Hong Kong Council of Social Service (HKCSS), participating in the fair for the first time, is showcasing a range of GeronTech and related products, covering areas such as rehabilitation and mobility assistance, cognitive impairment support for patients and carers, and smart home solutions. HKCSS is also introducing its GeronTech education and rental services, along with its online platform that enables the public to learn about and hire GeronTech equipment. Users such as the elderly, people in rehabilitation, and carers can try out products, and rent or purchase them as needed, with support from a cross-disciplinary professional team. Through the Medical Fair, HKCSS aims to attract collaboration with other businesses to expand its services and benefit a wider segment of the community.For green solutions, MassPhoton (Booth No: 3F-H18), also from the HKSTP Pavilion, presents an ultraviolet disinfection system that combines semiconductor and smart control technologies, delivering more efficient and energy-saving disinfection for air, water and surfaces.This year’s Medical Fair has attracted some 300 exhibitors from 13 countries and regions. Participating with pavilions for the first time are Israel, Thailand, and the UK, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg. Highlighting Hong Kong’s strength in medical innovation, seven local universities, over 30 innovative technology companies at the HKSTP pavilion, and more than 20 medical enterprises brought by the HKMHDIA are participating.The exhibition features a range of thematic zones, including Biotechnology, Hospital Equipment, Rehabilitation and Elderly Care Products, and Start-up and HKMHDIA zones.  Highlight exhibits include AI-powered rehabilitation systems, portable ultrasound diagnostic systems, and smart hospital robots, demonstrating the frontiers of medical and healthcare technology.During the Medical Fair, there will be forums, seminars and networking receptions. Two forums focused on the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) healthcare sector will take place tomorrow. The morning forum titled The MedTech Nexus of the Greater Bay Area, which is co-organised with the HKMHDIA, will feature industry experts sharing insights on intellectual property strategies for biomedical innovation, ways to integrate resources for GBA market development, and successful experiences in promoting medical technology in the GBA. The afternoon forum titled The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area will bring together experts from the Greater Bay Area Centre for Medical Device Evaluation and Inspection of National Medical Products Administration, the Medical Device Division of Department of Health, and SGS-CSTC Standards Technical Services Co., Ltd., to explore the latest developments, administrative systems and regulations in relevant fields, promoting cross-regional regulatory collaboration and fostering innovation through idea exchange.Using the HKTDC EXHIBITION+ hybrid model, global exhibitors, industry professionals, and buyers can continue business matching via the Click2Match smart business matching platform until 4 June, encouraging more cooperation.Aside from ASGH and the Medical Fair, IHW also features the Hospital Authority Convention, among many other industry events.Photo download: https://bit.ly/43xCK2bThe fifth Asia Summit on Global Health, jointly organised by the Hong Kong SAR Government and the Hong Kong Trade Development Council takes place at the Hong Kong Convention and Exhibition Centre from 26 to 27 May 2025 under the theme Fostering Global Collaboration for a Shared FutureDr Peter K N Lam, HKTDC Chairman, gives a welcome addressJohn Lee, Chief Executive of the Hong Kong SAR, delivers opening remarksProf Cao Xuetao, Deputy Director of the National Health Commission of the People’s Republic of China, delivers special remarksDr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation, delivers remarks at the opening session via video linkThe summit invites Prof John Hardy, Chair of Molecular Biology of Neurological Disease at UCL Queen Square Institute of Neurology. As an internationally renowned neurogeneticist, and Brain Prize recipient for "groundbreaking research on the basis of Alzheimer's disease", Prof John Hardy is known as the “father of Alzheimer’s disease genetic studies”ASGH deal-making facilitates one-on-one meetings both online and offline, aiming to bridge investors with healthcare projects from around the world and promote global collaborationASGH facilitates the signing of the partnership agreements, fostering concrete collaboration in various areas of the healthcare industry.The 16th Hong Kong International Medical and Healthcare Fair, themed Innovations Boosting Smart Health Experience, focuses on three key areas: MedTech, GeronTech and green solutions, featuring the latest medical health devices, products, and solutionsMedmind Technology, from Hong Kong Science and Technology Parks Corporation (HKSTP) Pavilion, introduces an app for cognitive impairment assessment. The tool allows middle-aged and elderly users to play digital mahjong and other games, with AI used to assess their cognitive status and offer personalised brain training, helping prevent and detect early signs of cognitive declineThe Hong Kong Council of Social Service (HKCSS), participating in the fair for the first time, showcases a range of GeronTech products, covering areas such as rehabilitation and mobility assistance, cognitive impairment support for patients and carers, and smart home solutionsThe Hungarian pavilion is once again participating in the Medical Fair, bringing devices for health assessment and medical-related coursesWebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enAsia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/enProgramme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programmeSpeakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speakerHong Kong International Medical and Healthcare Fair:https://www.hktdc.com/event/hkmedicalfair/enList of products: https://www.hktdc.com/event/hkmedicalfair/en/productActivity schedule: https://www.hktdc.com/event/hkmedicalfair/en/intelligence-hubMedia enquiriesFor enquiries, please contact Yuan Tung Financial Relations Limited:Louise SongTel: (852) 3428 5691Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Asia Summit on Global HealthSharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgHong Kong International Medical and Healthcare FairKelly ShekTel: (852) 2584 4537Email: kelly.yt.shek@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.com Copyright 2025 ACN Newswire via SeaPRwire.com.

BRATISLAVA, May 26, 2025 - (ACN Newswire via SeaPRwire.com) - The Council of Slovak Exporters welcomes the launch of the European Commission’s public consultation, announced in early May, focused on potential response measures regarding certain imported goods from the United States, should ongoing discussions on transatlantic economic cooperation not lead to a mutually beneficial outcome. Topics under consultation may include trade flows in sectors such as steel scrap and chemical products. The consultation will close on 10 June, coinciding with the Visegrad 4 Business Conference in Bratislava, where regional business leaders will convene to address global economic relations, EU market resilience, and other key issues critical to regional competitiveness."It is indeed symbolic that these consultations with the European Commission, which represent a much-needed link between the private and public sectors, are culminating on the day of our Visegrad 4 Business Conference, which aims to do exactly the same: To achieve demand-driven public policies and measures that will help Europe's industry and exports from losing global competitiveness." – said Lukáš Parízek, founder of the Visegrad 4 Business Conference and Chairman of the Council of Slovak Exporters.Top industry representatives from various sectors, as well as public officials and representatives of foreign diplomatic missions, have already confirmed their participation in this key regional business event. The conference, organized in the premises of the Bratislava Castle, will be opened with a speech by the Speaker of the Parliament Richard Raši. Maros Sefcovic, European Commissioner for Trade and Economic Security, will deliver his remarks and speak in an exclusive format during the first part of the day, as well as attend a roundtable discussion with industry leaders from the V4 region. Slovak Foreign Minister Juraj Blanár and Hungarian Foreign Minister Péter Szijjártó have also confirmed their participation in the closing part of the conference.Visegrad 4 Business Conference is jointly organised since 2022 by four business organisations from the V4 region: Council of Slovak Exporters, Czech Association of Exporters, Hungarian business association MAPI Klub and Polish Economic Forum. The conference is organised with the support of the International Visegrad Fund, individual V4 governments and private sponsors.For more information visit www.visegrad4business.eu.About the Council of Slovak ExportersThe Council of Slovak Exporters was established in 2020 as a response to COVID-19's impact on local businesses. With over 130 supporting companies, this business platform connects exporters and facilitates dialogue with state institutions, international organizations, and financial institutions. The Council publicly communicates in support of Slovak exporters, provides export-related assistance, organizes networking events, and connects relevant entities in international trade. The organization holds BRONZE "European Cluster Excellence Initiative" certification, operating at the European level.Social LinksX: https://x.com/Visegrad4BInstagram: https://www.instagram.com/visegrad4business/LinkedIn: https://www.linkedin.com/company/visegrad-4-business/Facebook: https://www.facebook.com/visegrad4business#Media ContactCouncil of Slovak ExportersVisegrad 4 Business Conference+421 914 201 101https://www.visegrad4business.eu/ Copyright 2025 ACN Newswire via SeaPRwire.com.

Kuala Lumpur, May 26, 2025 - (ACN Newswire via SeaPRwire.com) – CBL International Limited (NASDAQ: BANL) (“CBL” or the “Company”), the listing vehicle of Banle Group (“Banle” or the “Group”), a leading marine fuel logistics company in the Asia-Pacific region, today announced the official renaming of its Singapore-based wholly owned subsidiary, Majestic Energy (Singapore) Pte Ltd, to support its regional growth strategy.Effective immediately, Majestic Energy (Singapore) Pte Ltd has been officially renamed to Banle International (Singapore) Pte Ltd, reflecting the Group’s deepening commitment to the Singapore market and its strategic expansion into sustainable fuels.Singapore remains the world's largest bunkering hub, with annual sales close to 55 million metric tons in 2024, increased by 6% year-over-year as compared to 2023, according to Maritime & Port Authority of Singapore (“MPA”) statistics. While conventional fuels still dominate the market, demand for sustainable fuels such as biofuels, LNG, and methanol continues to rise steadily. Notably, biofuel sales in the first four months of 2025 in Singapore have already surpassed 50% of the total volume recorded in 2024, according to  MPA statistics.As the primary fuel bunkering hub in the Asia-Pacific region, Singapore serves as a strategic base for CBL’s regional expansion. CBL’s revenue in Singapore increased by 102% year-over-year in 2024 as compared to 2023. In March 2025, the Company launched its first biofuel supply services in Singapore — a key regional port — as part of its broader initiative to offer sustainable fuel alternatives across the region, followed by biofuel supply in Malaysia, Hong Kong and various ports in China. CBL’s biofuel sales volumes and sales surged over 600% year-over-year in 2024, supported by strengthened supplier relationships and reliable supply chains. These efforts help customers meet IMO GHG targets while offering sustainable, cost-effective alternatives.“Singapore plays a pivotal role in our long-term growth strategy,” said Dr. Teck Lim Chia, Chairman and CEO of CBL. “The renaming of our subsidiary underscores our strengthened presence in this critical market and reinforces our commitment to supporting the global maritime industry’s transition toward greener energy solutions.”Despite the increasing competition in Singapore’s bunkering sector, CBL continues to differentiate itself through its agile operations and customer-centric approach. The Company prides itself on its ability to adapt and tailor solutions to meet the specific needs of clients and suppliers, enabling it to capture new opportunities in both traditional and emerging fuel segments.Christofel Tian, our Head of Singapore, added "With our rebranding to Banle International (Singapore) Pte Ltd, we are not only aligning ourselves more closely with the Group’s identity but also signaling our long-term commitment to the Singapore market. As the global bunkering landscape evolves, especially with the rapid adoption of sustainable fuels, we are well-positioned to grow alongside Singapore’s vision of becoming a leader in sustainable maritime solutions."With its robust regulatory environment, mature infrastructure, and strong government support, Singapore is well-positioned to maintain its leadership in the global bunkering market — and CBL is committed to growing alongside it.About the Banle GroupCBL International Limited (Nasdaq: BANL) is the listing vehicle of Banle Group, a reputable marine fuel logistic company based in the Asia Pacific region that was established in 2015. We are committed to providing customers with one-stop solution for vessel refueling, which is referred to as bunkering facilitator in the bunkering industry. We facilitate vessel refueling mainly through local physical suppliers in over 60 major ports covering Belgium, China, Hong Kong, India, Japan, Korea, Malaysia, Mauritius, Panama, the Philippines, Singapore, Taiwan, Thailand, Turkey and Vietnam, as of 16 April 2025. The Group actively promotes the use of sustainable fuels and is awarded with the ISCC EU and ISCC Plus certifications.For more information about our company, please visit our website at: https://www.banle-intl.com.Forward-Looking StatementsCertain statements in this announcement are not historical facts but are forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “could,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan,” “should,” “would,” “plan,” “future,” “outlook,” “potential,” “project” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other performance metrics and projections of market opportunity. They involve known and unknown risks and uncertainties and are based on various assumptions, whether or not identified in this press release and on current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. Some important factors that could cause actual results to differ materially from those in any forward-looking statements could include changes in domestic and foreign business, markets, financial, political and legal conditions, geopolitical disruptions and other events that result in material changes in fuel prices. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.CBL INTERNATIONAL LIMITED (Incorporated in Cayman Islands with limited liabilities)For more information, please contact: CBL International Limited Email: investors@banle-intl.comStrategic Financial Relations LimitedShelly Cheng        Tel: (852) 2864 4857 Iris Au Yeung       Tel: (852) 2114 4913 Email:              sprg_cbl@sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

吉隆坡，2025年5月26日 - (亚太商讯 via SeaPRwire.com) - CBL International Limited（纳斯达克代码：BANL）（"CBL"或"公司"），万利集团（"万利"或"集团"）旗下的上市平台，是一家领先的亚太地区船用燃料物流公司，今日宣布正式更名其位于新加坡的全资子公司Majestic Energy (Singapore) Pte Ltd，以支持其区域增长战略。自即日起， Majestic Energy (Singapore) Pte Ltd 正式更名为 Banle International (Singapore) Pte Ltd ，反映出集团对新加坡市场的深入承诺，以及向可持续燃料领域扩展的战略方向。根据新加坡海事及港务管理局(MPA)的数据，新加坡仍是全球最大的船用燃料加注枢纽，2024年的年销售量接近5,500万吨，较2023年同比增长6%。尽管传统燃料仍占据市场主导地位，但生物燃料、液化天然气(LNG)和甲醇等可持续燃料的需求持续稳步上升。尤其值得注意的是，根据新加坡海事及港务管理局统计，2025年前四个月的新加坡生物燃料销量已超过2024年全年总量的一半。作为亚太地区主要的燃料加注枢纽，新加坡是CBL区域扩张的重要战略基地。2024财年，CBL在新加坡的收入同比2023财年增长了102%。继于马来西亚、香港及中国多个港口开展生物燃料供应业务，2025年3月，公司在新加坡这一关键区域港口启动了首次生物燃料供应服务，作为其在整个区域提供可持续替代燃料更广泛计划的一部分。受供应商关系强化与供应链稳定的支持，CBL的2024年生物燃料销售量和销售额实现了同比增长超600%，助力客户实现国际海事组织（IMO）温室气体（GHG）减排目标，同时提供可持续且具有成本效益的替代方案。"新加坡在我们的长期发展战略中扮演着关键角色，"集团主席兼行政总裁谢威廉博士表示。"此次子公司的更名彰显了我们在这一关键市场实力的增强，并重申我们支持全球航运业向绿色能源转型的承诺。"尽管新加坡的燃料加注行业竞争日益激烈，CBL仍凭借灵活的运营模式和以客户为中心的服务理念脱颖而出。公司自豪于能够根据客户和供应商的具体需求定制解决方案，从而在传统和新兴燃料领域中把握新机遇。新加坡区域主管田祥福先生补充道："随着我们品牌升级为Banle International (Singapore) Pte Ltd，我们不仅更加贴近集团的整体品牌形象，也进一步表明了我们对新加坡市场的长期承诺。随着全球燃料加注格局的发展，特别是在可持续燃料快速采用的背景下，我们已做好充分准备，与新加坡成为可持续海事解决方案领导者的愿景共同成长。"凭借健全的监管环境、成熟的基础设施以及强大的政府支持，新加坡具备持续引领全球燃料加注市场的条件，而CBL也将坚定地与其一同成长。前瞻性声明本公吿中的某些陈述并非历史事实，而是前瞻性陈述。前瞻性陈述一般使用"相信"、"可能"、"可以"、"将要"、"估计"、"继续"、"预期"、"打算"、"期望"、"计划"、"应该"、"将会"、"规划"、"未来"、"展望"、"潜力"、"预测"等类似词语来预测或表达未来事件或趋势或不属于历史事项的陈述，但不使用这些词语并不意味著陈述并非前瞻性。这些前瞻性陈述包括但不限于对其他绩效指标的估计和预测，以及对市场机会的预测。这些信息涉及已知和未知的风险和不确定性，并基于各种假设（无论本新闻稿中是否指明）以及BANL管理层的当前预期，而非对实际业绩的预测。这些前瞻性陈述仅供帮助目的，不得被任何投资者作为且不得被依赖为对事实或可能性的担保、保证、预测或确凿陈述。实际事件和情况难以或不可能预测，也会与假设不同。许多实际事件和情况不在BANL的控制范围内。一些重要因素可能导致实际结果与任何前瞻性陈述存在实质性差异，包括国内外商业、燃料价格和关税、市场、金融、政治、法律环境、地缘政治及其他导致燃料价格发生重大变化的事件的影响。公司没有义务公开更新或修改任何前瞻性陈述来反映随后发生的事件或情况或预期的变化，法律可能要求者除外。尽管公司认为该等前瞻性陈述中表达的预期合理，但不能向您保证此类预期最终正确无误。公司提醒投资者实际结果可能与预期结果存在重大差异，并鼓励投资者细阅公司的注册声明和向SEC提交的其他文件所载可能影响其未来业绩的其他因素。关于万利集团万利集团成立于 2015 年，以CBL International Limited（纳斯达克：BANL）在纳斯达克股票市场上市。我们致力于为客户提供一站式燃油供应服务，被业内称为燃油供应服务商。截至2025年4月 16日，我们主要通过当地实体供货商为船舶提供燃油加注服务，遍布比利时、中国、香港、印度、日本、韩国、马来西亚、毛里裘斯、巴拿马、菲律宾、新加坡、台湾、泰国、土耳其和越南，共覆盖超过60个港口。集团积极推动可持续燃料，并已取得ISCC EU和ISCC Plus认证。如欲了解更多信息，请到集团网站 https://www.banle-intl.com 浏览。如需更多资讯，请联系：CBL International Limited电邮：investors@banle-intl.com纵横财经公关顾问有限公司郑松雪 电话：(852) 2864 4834欧阳蔚雯 电话：(852) 2114 4913电邮：sprg_cbl@sprg.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com.

AI-powered real-time deepfake detection solution, Aletheia, recognised for effectiveness, innovation, and operational scalabilityHONG KONG, May 27, 2025 - (ACN Newswire via SeaPRwire.com) - Ensign InfoSecurity (“Ensign”), one of Asia’s largest cybersecurity service providers, has won the “Product Excellence - Cybersecurity Product of the Year” award at the Tech Fest Hong Kong Awards 2025 for its proprietary solution, *Aletheia, an AI-powered real-time deepfake detection tool that enhances digital trust and protects organisations against multimedia-based deception.Developed by Ensign Labs, Aletheia uses multi-modal artificial intelligence to identify manipulated video and audio content. Available across endpoint software or a chrome browser plug-in, the solution delivers real-time detection to support secure virtual meetings, digital identity verification, and high-assurance communication environments.Built for operational environments, Aletheia performs all detection on-device, ensuring privacy-first analysis without cloud dependency. It integrates seamlessly with Security Information and Event Management (SIEM) systems to provide real-time alerts, enabling security teams to respond swiftly with forensic-ready evidence for investigation and resolution.“This award reinforces the purpose behind our work,” said Nicky Au, General Manager, Greater China Region, Ensign InfoSecurity (East Asia) Limited. “As threats grow more sophisticated, the ability to safeguard digital interactions, authentically and at speed, has become critical to business resilience and public trust.Cybersecurity is not achieved in isolation. It requires coordination, transparency, and shared intelligence. At Ensign, we are committed to working alongside our peers, partners, and clients to stay ahead of what’s next.”Aletheia is built to meet the evolving needs of sectors most vulnerable to digital deception. Examples of its use are varied. In financial services, it adds a line of defence during voice authentication and transaction validation. For media organisations, it supports source verification and editorial integrity. Government agencies can rely on it to validate emergency communications, while Human Resource departments use it to screen for audio-visual fraud in remote interviews and recruitment processes.This award underscores Ensign’s commitment to developing applied, scalable technologies through its in-house R&D. Aletheia is part of a broader portfolio of AI-powered capabilities that include cyber analytics, digital risk monitoring, and automated threat detection, designed to equip enterprises and public institutions with future-ready defence strategies.*Aletheia, in Greek mythology, refers to the Goddess of truth, symbolising the pursuit of truth and transparency.About Ensign InfoSecurityEnsign InfoSecurity is the largest cybersecurity service provider in Asia. Headquartered in Singapore, Ensign offers bespoke solutions and services to address their clients’ cybersecurity needs. Their core competencies are in the provision of cybersecurity advisory and assurance services, architecture design and systems integration services, and managed security services for advanced threat detection, threat hunting, and incident response. Underpinning these competencies is in-house research and development in cybersecurity. Ensign has two decades of proven track record as a trusted and relevant service provider, serving clients from the public and private sectors in the Asia Pacific region.For more information, visit www.ensigninfosecurity.com, or email media@ensigninfosecurity.com Copyright 2025 ACN Newswire via SeaPRwire.com.